New

Global ETF Survey Is Live! 600+ ETF Professionals Weigh In. See Results →

Advertisement
Advertisement

VHTvsXLVETF Comparison

ETF 1
VHT

Vanguard Health Care ETF

This fund is part of
US Health Care
-1.77%
VS
ETF 2
XLV

State Street Health Care Select Sector SPDR ETF

This fund is part of
US Health Care
-1.77%

Vanguard Health Care ETF (VHT) and State Street Health Care Select Sector SPDR ETF (XLV) belong to the same industry segment: US Health Care. VHT's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. In contrast, XLV's top sector exposures are Healthcare, Consumer Non-Cyclicals and Finance. VHT is more expensive with a Total Expense Ratio (TER) of 0.09%, versus 0.08% for XLV. VHT is up 15.12% year-to-date (YTD) with +$540M in YTD flows. XLV performs better with 18.51% YTD performance, and +$1.81B in YTD flows. Run a side-by-side ETF comparison of VHT and XLV below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

VHT vs XLV performance and flow charts

Performance

0.02.04.06.08.0%Oct 19Oct 26Nov 2Nov 9Nov 16

Cumulative Flows

0 B0.5 B1 B1.5 BOct 19Oct 26Nov 2Nov 9Nov 16

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 11/19/2026
1M3MYTD1Y3Y5Y
Perf.
VHT
XLV
+0.66%+3.19%
-0.16%+7.21%
+15.12%+18.51%
+17.53%+20.76%
+46.27%+47.65%
+38.76%+46.89%
Flows
VHT
XLV
+$543M+$876M
+$491M+$890M
+$540M+$1.81B
+$675M+$1.63B
-$1.21B-$2.04B
-$650M+$3.26B
Volatility and drawdown
3M1Y3Y5Y
Volatility
VHT
XLV
+18.30%+19.40%
+16.75%+17.06%
+15.12%+15.20%
+15.81%+15.43%
Max drawdown
VHT
XLV
-6.64%-5.81%
-10.39%-10.51%
-16.88%-17.05%
-17.77%-17.05%
Max drawdown duration
VHT
XLV
15d56d
169d116d
435d444d
767d444d
Trading data

Create an account to view trading data

Join for free
VHT
XLV
Last sale
11/20/2026 at 2:44 PM
$331.06
$179.49
Previous close
11/19/2026
$327.99
$177.46
Consolidated volume
11/19/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of October 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
VHT
XLV
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 11/20/2026 at 2:44 PM
Live
Closed
VHT
XLV
Last price
$331.06
$179.49
1D performance
+0.94%
+1.14%
AuM$20.24 B$48.25 B
E/R0.09%0.08%
Characteristics
VHT
XLV
Management strategyPassivePassive
ProviderVanguardState Street Investment Management
BenchmarkMSCI US IMI Health Care 25/50 IndexS&P Health Care Select Sector Index
N° of holdings40861
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJanuary 26, 2004December 16, 1998
ESGNoNo
Advertisement
Exposure

Countries

VHT
USA
96.83%
Other
3.17%
XLV
USA
97.6%
Other
2.4%

Sectors

VHT
Healthcare
97.77%
Other
2.23%
XLV
Healthcare
97.95%
Other
2.05%
Advertisement

Diversification

VHT

Total weight of top 15 holdings out of 15

60.91%
XLV

Total weight of top 15 holdings out of 15

71.29%

Top 15 holdings

Data as of September 30, 2026
VHT
Eli Lilly & Co.
12.93%
Johnson & Johnson
8.78%
AbbVie, Inc.
6.45%
Merck & Co., Inc.
5.01%
UnitedHealth Group, Inc.
4.65%
Thermo Fisher Scientific, Inc.
3.50%
Amgen, Inc.
3.18%
Gilead Sciences, Inc.
2.58%
Abbott Laboratories
2.40%
Pfizer Inc.
2.27%
Intuitive Surgical, Inc.
2.01%
Danaher Corp.
1.97%
Vertex Pharmaceuticals, Inc.
1.85%
Bristol Myers Squibb Co.
1.78%
Medtronic Plc
1.54%
XLV
Eli Lilly & Co.
15.13%
Johnson & Johnson
10.43%
AbbVie, Inc.
7.55%
Merck & Co., Inc.
5.86%
UnitedHealth Group, Inc.
5.38%
Thermo Fisher Scientific, Inc.
4.08%
Amgen, Inc.
3.72%
Gilead Sciences, Inc.
3.02%
Abbott Laboratories
2.79%
Pfizer Inc.
2.66%
Intuitive Surgical, Inc.
2.35%
Danaher Corp.
2.27%
Vertex Pharmaceuticals, Inc.
2.17%
Bristol Myers Squibb Co.
2.08%
Medtronic Plc
1.81%
Frequently asked questions about VHT and XLV

How have the VHT and XLV ETFs performed in 2026?

As of November 19, 2026, VHT is up 15.12% year-to-date (YTD), while XLV has returned 18.51%. That puts XLV better performer ahead so far this year.

Which ETF is attracting more investor money: VHT or XLV?

Year-to-date, the VHT ETF saw +$540M in flows, compared to +$1.81B for XLV.

Which ETF is more volatile: VHT or XLV?

Over the past year, VHT had a volatility of 16.75%, while XLV experienced 17.06%.

Which ETF is bigger: VHT or XLV?

As of November 19, 2026, VHT holds $20.24 B in assets under management (AUM), while XLV manages $48.25 B.

What sectors do the VHT and XLV ETFs invest in?

VHT leans toward sectors like Healthcare. Meanwhile, XLV focuses on Healthcare.

What are the top holdings of the VHT ETF and XLV ETF?

VHT top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. XLV holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: VHT or XLV?

VHT holds 408 securities with 60.91% of its assets in the top 15. XLV has 61 securities and a top 15 weight of 71.29%.

Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026